Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

CNS medication studies

CNS medication trials start with a conversation

You begin with a short conversation, which costs nothing and carries no obligation. From there, CNS Medication Trials helps you learn about CNS medication trials and, if you are interested, connects you with study teams.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed
Tablets in a small dish beside a glass of water
Photo by Pavel Danilyuk on Pexels
All locations

CNS medication studies in numbers

CNS medication studies recruiting in the U.S.
410
states with a study site
50
cities with a study site
595
studies that accept healthy volunteers
66

Source: ClinicalTrials.gov. Data processed .

Find CNS medication studies near you

These states have the most studies recruiting right now.

CNS medication studies recruiting now

As of November 17, 2026, 410 CNS medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a medication, as each study is coded in the registry. This is what they have in common.

What they test

  • medications410
  • other approaches45
  • devices23
  • biologics such as vaccines or antibodies21
  • behavioral approaches such as talk therapy or training19

A study can test more than one.

Main purpose

  • treating a condition317
  • basic science30
  • diagnosis25
  • other purposes18

Phase

  • Early Phase 123
  • Phase 151
  • Phase 1/229
  • Phase 2122
  • Phase 2/38
  • Phase 3103
  • Phase 469
  • No phase5

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other202
  • industry181
  • government27

Who they enroll

  • adults (18 to 64)367
  • older adults (65 and over)289
  • children (under 18)60

66 also accept healthy volunteers.

Where: sites in 50 states. The cities with the most are New York, NY (84), Atlanta, GA (68), Houston, TX (66), Chicago, IL (62), Philadelphia, PA (59), Boston, MA (58), Miami, FL (55), Tampa, FL (54).

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 410 studies.

Recruiting now, by research area

Recently updated CNS medication studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

    • Phase 1
    • Ages 18 to 70
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT03973268 · updated
  2. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Aurora, CO · Bethlehem, PA · Boston, MA · and 41 more U.S. locations
    Registry record
    NCT06623422 · updated
  3. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Albuquerque, NM · Altamonte Springs, FL · Athens, GA · and 30 more U.S. locations
    Registry record
    NCT06841354 · updated
  4. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Albuquerque, NM · Anchorage, AK · Bethlehem, PA · and 47 more U.S. locations
    Registry record
    NCT06952504 · updated
  5. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Altamonte Springs, FL · Baltimore, MD · Boston, MA · and 53 more U.S. locations
    Registry record
    NCT06966700 · updated
  6. 18F-mFBG Cardiac Uptake With Lewy Body Dementia

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
    Recruiting in
    Houston, TX
    Registry record
    NCT07176286 · updated

Source: ClinicalTrials.gov. Data processed .

Not sure which study fits?

Tell a coordinator what you are looking for. They will explain which CNS medication studies may be worth a closer look and what the next step is. Asking does not commit you to anything.

Call (888) 927-5768

How taking part works

You move through four steps. At each one, whether to go further is up to you.

  1. Tell us what you are looking for

    You call or fill in a short form, telling us which condition or kind of study you have in mind.

  2. Talk with a coordinator

    Next you hear from a coordinator, who goes over which studies might be a match and answers what you ask in plain language.

  3. Meet the study team

    Next comes a closer conversation, if you choose to keep going. The team running the CNS medication trial explains it to you thoroughly and works out whether you are eligible.

  4. Decide what is right for you

    From here on, the decision stays with you. Joining a CNS medication trial is your choice every time, and if you later think differently, you are free to withdraw whenever you wish, whatever your reason.

Research areas

These are the areas where we can help you look into studies.

  • Depression studies

    When you browse depression studies, you will find research designed around adults living with depressive symptoms. What gets studied ranges from investigational medications to devices and approaches built on talk therapy.

  • Schizophrenia studies

    In schizophrenia research you will come across support programs as well as medications that remain investigational. Part of that work targets symptoms which care available today does not address.

  • Bipolar Disorder studies

    Research in bipolar disorder covers investigational options for managing mood episodes, along with ways of supporting stability over the long term.

  • ADHD studies

    In ADHD research, investigational medications and approaches that do not involve medication are evaluated for attention and focus in adults.

  • Parkinson's Disease studies

    For Parkinson's disease, research examines investigational medications, devices, and exercise or therapy programs. The focus is on both movement and non-movement symptoms.

  • Multiple Sclerosis (MS) studies

    For multiple sclerosis, studies look at investigational medications and rehabilitation approaches, covering both relapsing and progressive forms of MS.

  • Epilepsy studies

    If you live with seizures, epilepsy research is where investigational medications, devices, and monitoring tools are evaluated.

  • Migraine studies

    With migraine, research examines investigational options for two things: preventing attacks, and relief after an attack has begun.

  • Not sure where you fit?

    Give us a few details about what you have in mind, and a coordinator will point you in the right direction.

Why people take part in CNS medication studies

Before you decide, it helps to talk through why a CNS medication trial interests you. Reasons vary from person to person, and all of them deserve that conversation.

  • A research team would follow your health closely while the study runs.
  • You could learn more about a condition you live with.
  • You would be helping researchers answer questions, and those answers might influence how others are cared for later on.

Keep in mind that a study is a form of research rather than treatment. Whether taking part will help you personally is something no one is able to promise. For a plain explanation, read what a clinical trial is.

Your safety and your rights come first

Before you agree to anything, the details of a CNS medication trial come to you in writing. Earlier still, before any study can enroll a single person, an independent ethics committee has to review it. There are separate pages on what informed consent involves, on how each study gets reviewed and monitored, and on the rights you keep for as long as you are involved.

Common questions about CNS medication studies

Does it cost anything to ask about a study?

No. There is no charge for a conversation with CNS Medication Trials. Questions are just questions, and raising them signs you up for nothing.

Do I have to take part if I call?

No. At every step, continuing is your decision, and stopping is open to you at any time.

Who decides whether I can join a study?

Eligibility is decided by the study team once you have had a screening visit. Every CNS medication trial sets requirements of its own. Our page on how screening works explains more.

Ask about CNS medication studies

A coordinator will contact you once you have shared a few details. Reaching out about a CNS medication trial leaves you free of any obligation.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Learn more from independent sources

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call